Showing results (71-80 of 663) with videos related to

Sort By:
Pageof 67
The Lancet. Rheumatology|January 22, 2024
Artificial intelligence and high-dimensional technologies in the theragnosis of systemic lupus erythematosusKatherine Nay Yaung, Joo Guan Yeo, Pavanish Kumar, et al.
Annals of the Rheumatic Diseases|November 27, 2010
Development and preliminary validation of a paediatric-targeted MRI scoring system for the assessment of disease activity and damage in juvenile idiopathic arthritisClara Malattia, Maria Beatrice Damasio, Angela Pistorio, et al.
Arthritis Care & Research|August 29, 2013
Agreement among musculoskeletal pediatric specialists in the assessment of radiographic joint damage in juvenile idiopathic arthritisAna-Luisa Rodriguez-Lozano, Gabriella Giancane, Rossana Pignataro, et al.
Clinical and Experimental Rheumatology|August 29, 2013
Introducing new tools for assessment of parent- and child-reported outcomes in paediatric rheumatology practice: a work in progressGiovanni Filocamo, Alessandro Consolaro, Cristina Ferrari, et al.
Expert Opinion on Biological Therapy|June 23, 2026
Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with a primary focus on rituximab and belimumabFederico Diomeda, Valentina Natoli, Adele Civino, et al.
Nature Reviews. Rheumatology|February 6, 2024
Treatment of non-systemic juvenile idiopathic arthritisSusan Shenoi, Gerd Horneff, Amita Aggarwal, et al.
Arthritis and Rheumatism|August 1, 2008
Validation of the Childhood Health Assessment Questionnaire in active juvenile systemic lupus erythematosusSilvia Meiorin, Angela Pistorio, Angelo Ravelli, et al.
Arthritis Care & Research|May 28, 2011
Development and initial validation of composite parent- and child-centered disease assessment indices for juvenile idiopathic arthritisAlessandro Consolaro, Nicolino Ruperto, Angela Pistorio, et al.
Arthritis and Rheumatism|September 29, 2011
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic featuresNicolino Ruperto, Pierre Quartier, Nico Wulffraat, et al.
Rheumatology (Oxford, England)|March 27, 2010
A new short and simple health-related quality of life measurement for paediatric rheumatic diseases: initial validation in juvenile idiopathic arthritisGiovanni Filocamo, Benedetta Schiappapietra, Marta Bertamino, et al.
Pageof 67